Hu Fang, Rishishwar Lavanya, Sivadas Ambily, Mitchell Gabriel J, Jordan I King, Murphy Timothy F, Gilsdorf Janet R, Mayer Leonard W, Wang Xin
Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
School of Biology, Georgia Institute of Technology, Atlanta, Georgia, USA.
J Clin Microbiol. 2016 Dec;54(12):3010-3017. doi: 10.1128/JCM.01511-16. Epub 2016 Oct 5.
Haemophilus haemolyticus has been recently discovered to have the potential to cause invasive disease. It is closely related to nontypeable Haemophilus influenzae (NT H. influenzae). NT H. influenzae and H. haemolyticus are often misidentified because none of the existing tests targeting the known phenotypes of H. haemolyticus are able to specifically identify H. haemolyticus Through comparative genomic analysis of H. haemolyticus and NT H. influenzae, we identified genes unique to H. haemolyticus that can be used as targets for the identification of H. haemolyticus A real-time PCR targeting purT (encoding phosphoribosylglycinamide formyltransferase 2 in the purine synthesis pathway) was developed and evaluated. The lower limit of detection was 40 genomes/PCR; the sensitivity and specificity in detecting H. haemolyticus were 98.9% and 97%, respectively. To improve the discrimination of H. haemolyticus and NT H. influenzae, a testing scheme combining two targets (H. haemolyticus purT and H. influenzae hpd, encoding protein D lipoprotein) was also evaluated and showed 96.7% sensitivity and 98.2% specificity for the identification of H. haemolyticus and 92.8% sensitivity and 100% specificity for the identification of H. influenzae, respectively. The dual-target testing scheme can be used for the diagnosis and surveillance of infection and disease caused by H. haemolyticus and NT H. influenzae.
最近发现溶血嗜血杆菌有引发侵袭性疾病的可能。它与不可分型流感嗜血杆菌(NT 流感嗜血杆菌)密切相关。NT 流感嗜血杆菌和溶血嗜血杆菌常被误识别,因为现有的针对溶血嗜血杆菌已知表型的检测方法均无法特异性识别溶血嗜血杆菌。通过对溶血嗜血杆菌和 NT 流感嗜血杆菌进行比较基因组分析,我们鉴定出了溶血嗜血杆菌特有的基因,这些基因可作为识别溶血嗜血杆菌的靶点。开发并评估了一种针对 purT(在嘌呤合成途径中编码磷酸核糖甘氨酰胺甲酰基转移酶 2)的实时 PCR。检测下限为 40 个基因组/PCR;检测溶血嗜血杆菌的灵敏度和特异性分别为 98.9%和 97%。为提高对溶血嗜血杆菌和 NT 流感嗜血杆菌的鉴别能力,还评估了一种结合两个靶点(溶血嗜血杆菌的 purT 和流感嗜血杆菌的 hpd,编码蛋白 D 脂蛋白)的检测方案,该方案对溶血嗜血杆菌的鉴定灵敏度和特异性分别为 96.7%和 98.2%,对流感嗜血杆菌的鉴定灵敏度和特异性分别为 92.8%和 100%。双靶点检测方案可用于诊断和监测由溶血嗜血杆菌和 NT 流感嗜血杆菌引起的感染和疾病。